This is a Retrospective Observational Study Looking at the Characteristics and Outcomes of Participants Taking Inflectra Using the CorEvitas Rheumatoid Arthritis Registry

Pfizer

Status: Completed

Conditions: Arthritis, Rheumatoid

Treatments: Drug: Inflectra

Study type: Observational

Funder types: Industry

Identifiers

NCT05375942

C1231007

Details and patient eligibility

About

This is a retrospective observational study looking at the characteristics and outcomes of participants taking Inflectra using the CorEvitas Rheumatoid Arthritis Registry.

Enrollment: 255 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Be at least 18 years of age
• Have been diagnosed with RA by a rheumatologist
• Have initiated treatment with Inflectra
• Had assessment of effectiveness in patients who have at least one follow up visit.

Exclusion criteria

• No additional exclusion criteria

Trial design

255 participants in 2 patient groups

characteristics of patients newly initiated on Inflectra

Treatment:

Drug: Inflectra

Drug: Inflectra

outcomes after initiating Inflectra

Treatment:

Drug: Inflectra

Drug: Inflectra